Immuno-Oncology Conference, London – agenda released

Immuno-Oncology is a fast-paced field with massive potential to deliver successful and durable cancer therapies.
SMi's Immuno-Oncology Conference (26 – 27 September 2018, London, UK) will focus on a few key areas of the field with representation of the whole industry, under each area. These areas will be drawn together to look towards the future of Immuno-oncology and how the field can progress.

Agenda - Valuable time is spent to discover the latest trends and hottest topics in the industry to provide the best possible agenda for attendees. 15+ engaging presentations/case studies/keynote addresses, including:

• Targeting immune checkpoints with Humabody VH therapeutics
• Recent advances in providing durable disease control with Keytruda as an anti-cancer therapy
• Tumour mutation burden and the potential of its use as an indication of treatment choice
• Unwanted immunogenicity and functionality testing of immuno-oncology drugs
• New techniques, such as the emerging applications of liquid biopsies, in Immuno-Oncology

Speakers - Top representation of industry leaders. 15+ leading experts in Immuno-Oncology field, including:

• James Legg, Vice President R&D, Crescendo Biologics
• Andrew Exley, Medical Assessor, MHRA
• Harry Smith, Medical Scientist, Gilead Sciences
• Grace Macaulay, Global Safety Physician Patient Safety Oncology, MedImmune
• David Giljohan, CEO, Exicure
• Kandeepan Ganeshalingam, Executive Director, Oncology Therapeutic Area Head, European Clinical Development, MSD
• Rochana Wickramasinghe, Director of Oncology Evaluation, AstraZeneca

Workshops - Carefully selected topics for further on-sight training. 2 pre-conference workshops (25 September 2018) to provide in-depth knowledge on specific topics:

• Strategic Competitive Intelligence in the Immuno-Oncology space - hosted by LucidQuest Ventures
• Could the Microbiome boost Cancer Immuno-Therapy - hosted by ImmuneBiotech and Lund University

Networking - it is at the forefront of SMi events. 5+ hours of pure networking guaranteed.
Follow event updates to be in the know about who will be joining the conversation.

Further details on http://www.immuno-oncology-conference.com/openpr

Twitter - @SMIpharm & #immunooncologysmi
LinkedIn - SMi Pharma

CONTACT:
+44 (0)20 7827 6000
ldurneva@smi-online.co.uk

About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network.

1 Westminster Bridge Road

This release was published on openPR.